# Irinotecan, Gemcitabine, Chemotherapy for Biliary Tract Cancer

> **NCT00832689** · PHASE2 · COMPLETED · sponsor: **Yonsei University** · enrollment: 39 (actual)

## Conditions studied

- Biliary Tract Cancer

## Interventions

- **DRUG:** Irinotecan and Gemcitabine

## Key facts

- **NCT ID:** NCT00832689
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2010-02
- **Final completion:** 2010-03
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2011-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00832689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00832689, "Irinotecan, Gemcitabine, Chemotherapy for Biliary Tract Cancer". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00832689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*